Physician profile
Andrew J Snider
NPI 1134597339
$1,049.16
in general payments reported to CMS, 2019-2025
21 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.16 · 2023: $99.26 · 2024: $377 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $208.10 | 2023-2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $84.58 | 2024-2025 | |
| Exact Sciences Corporation | $79.45 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $76.81 | 2023-2025 | |
| Glaxosmithkline, LLC. | $69.14 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $65.31 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Ibsa Pharma INC. | $55.15 | 2025 | Flector, Tirosint, Licart |
| Amgen INC. | $49.03 | 2024 | Repatha, Otezla, Tepezza |
| Insulet Corporation | $46.86 | 2024-2025 | Omnipod |
| Pfizer INC. | $44.60 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.08 | 2024 | Synjardy, Jardiance, Tradjenta |
| Corcept Therapeutics | $32.66 | 2025 | Korlym |
| Tolmar, INC. | $32.41 | 2024 | |
| Madrigal Pharmaceuticals | $32.13 | 2025 | Rezdiffra |
| Kyowa Kirin, INC. | $27.15 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $26.14 | 2025 | |
| Merck Sharp & Dohme LLC | $23.66 | 2025 | Lagevrio |
| Abbott Laboratories | $16.85 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $14.77 | 2025 | Airsupra |
| Biohaven Pharmaceutical Holding Company LTD. | $14.16 | 2022 | |
| Cequr Corporation | $13.12 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Snider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.